The Pandemic Will End: How and Why
In many ways we’ve been fortunate. Despite a pandemic, society has not broken down.
The Pandemic Will End: How and Why Read More »
In many ways we’ve been fortunate. Despite a pandemic, society has not broken down.
The Pandemic Will End: How and Why Read More »
The field of epilepsy has seen great strides in the last couple of decades.
Epilepsy Patient Newsletter February 2020 Read More »
Aducanumab, the first Alzheimer’s-modifying therapy, submitted to the FDA. Can Biogen recover from their errors?
Alzheimer’s Patient Newsletter February 2020 Read More »
“If you have a loved one with dementia, you know this can be a heart-wrenching process. You cannot change the person. . . . You have to meet them where they are, roll with it, and speak with love and patience. It was a pleasure to speak to Dr. David Weisman, a neurologist.”
Dr. Weisman interviewed on Boomer Living podcast Read More »
The field of MS research has had amazing success in the last two decades.
MS Patient Newsletter December 2019 Read More »
Multiple sclerosis (MS) is an autoimmune disease in which the immune system misrecognizes part of the brain called myelin.
MS Physician Newsletter October 2019 Read More »
Early on in their careers, two neurologists became involved in advocacy issues on behalf of neurology on a national, regional, and local level.
Dr. Klein featured in Neurology Today Read More »
One day, one of the trials in Alzheimer’s disease will be positive. We think this trial may already be underway.
Alzheimer’s Patient Newsletter July 2019 Read More »
Dr. Klein has been appointed Chair of the Medical Economics and Practice committee, as well as serving on the Board of Directors.
Dr. Klein named to the AAN Board of Directors Read More »
We continue to fight for a disease modifying treatment in Alzheimer’s disease despite recent setbacks.
Alzheimer’s Physician Newsletter May 2019 Read More »